Biofrontera AG (ETR:B8FK)
Germany · Delayed Price · Currency is EUR 2.530
0.00 (0.00%)
Aug 5, 2026, 5:44 PM CET
Biofrontera AG Market Cap
Biofrontera AG has a market cap or net worth of €15.62 million as of August 5, 2026. Its market cap has decreased by -6.55% in one year.
Market Cap
15.62M
Enterprise Value
11.87M
Revenue
13.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.53
ChartMarket Cap Chart
Since October 31, 2006, Biofrontera AG's market cap has decreased from 38.05M to 15.62M, a decrease of -58.95%. That is a compound annual growth rate of -4.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 15.62M | 5.33% |
| Dec 30, 2025 | 14.83M | 13.49% |
| Dec 30, 2024 | 13.07M | -48.94% |
| Dec 29, 2023 | 25.59M | -73.70% |
| Dec 30, 2022 | 97.31M | 15.92% |
| Dec 30, 2021 | 83.94M | -42.36% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 61.93B |
| Bayer Aktiengesellschaft | 46.29B |
| Siemens Healthineers AG | 43.53B |
| Fresenius SE & Co. KGaA | 25.22B |
| Pentixapharm Holding AG | 47.21M |
| MeVis Medical Solutions AG | 42.59M |
| NanoRepro AG | 25.86M |
| aap Implantate AG | 21.56M |